Overcoming therapy resistance in pancreatic cancer: challenges and emerging strategies
Advanced Drug Delivery Reviews · 2025-09 · 224 · 115647
DOI: 10.1016/j.addr.2025.115647 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Advanced Drug Delivery Reviews, 2025-09. Verfasst von Taymin du Toit-Thompson und 7 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine and Health, University of Sydney, Australia; Kolling Institute of Medical Research, University of Sydney, St Leonards, Sydney, Au…. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Drug Resistance, Neoplasm, Antineoplastic Agents. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 889 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Pancreatic cancer (PC) is one of the deadliest types of cancer, with a 5-year survival rate of ∼12.5 %. It is expected to become the second leading cause of cancer-related deaths by 2030. Despite recent advances in treatment options by the advent of various targeted and immunotherapies, their benefits have not been actualized for PC patients and chemotherapy remains the mainstay systemic therapeutic option for these patients. However, the majority of PC tumors have a highly chemo-resistant phenotype, leading to therapeutic failure. This review provides a comprehensive overview of the established mechanisms related to chemoresistance in PC and provides insight into emerging theories, including the potential role of the microbiome in modulating therapeutic responsiveness. It further discusses potential opportunities to explore to overcome this critical clinical problem.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Medicine and Health, University of Sydney, Australia; Kolling Institute of Medical Research, University of Sydney, St Leonards, Sydney, Australia.
- Faculty of Medicine and Health, University of Sydney, Australia; Northern Sydney Cancer Centre, Royal North Shore Hospital, St Leonards, NSW, Australia.
- Faculty of Medicine and Health, University of Sydney, Australia; Kolling Institute of Medical Research, University of Sydney, St Leonards, Sydney, Australia; Cancer Diagnosis and Pathology Group, Kolling Institute of Me…
- Faculty of Medicine and Health, University of Sydney, Australia; Australian Pancreatic Centre, St Leonards, Sydney, Australia; Upper GI Surgical Unit, Royal North Shore Hospital and North Shore Private Hospital, Austral…
- Faculty of Medicine and Health, University of Sydney, Australia; Kolling Institute of Medical Research, University of Sydney, St Leonards, Sydney, Australia. Electronic address: sumit.sahni@sydney.edu.au.
Zitieren
APA
du Toit-Thompson, T., Leck, L., Gillson, J., Pavlakis, N., Gill, A. J., Samra, J. S., Mittal, A., & Sahni, S. (2025). Overcoming therapy resistance in pancreatic cancer: challenges and emerging strategies. Advanced Drug Delivery Reviews, 224, 115647. https://doi.org/10.1016/j.addr.2025.115647
Vancouver
du Toit-Thompson T, Leck L, Gillson J, Pavlakis N, Gill AJ, Samra JS, et al. Overcoming therapy resistance in pancreatic cancer: challenges and emerging strategies. Advanced Drug Delivery Reviews. 2025;224:115647. doi:10.1016/j.addr.2025.115647
BibTeX
@article{duToitThompson2025,
author = {du Toit-Thompson, Taymin and Leck, Lionel and Gillson, Josef and Pavlakis, Nick and Gill, Anthony J and Samra, Jaswinder S and Mittal, Anubhav and Sahni, Sumit},
title = {Overcoming therapy resistance in pancreatic cancer: challenges and emerging strategies},
journal = {Advanced Drug Delivery Reviews},
year = {2025},
volume = {224},
pages = {115647},
doi = {10.1016/j.addr.2025.115647}
}
EUVIMED